SYMLIN Trademark

Trademark Overview

On Wednesday, January 14, 2004, a trademark application was filed for SYMLIN with the United States Patent and Trademark Office. The USPTO has given the SYMLIN trademark a serial number of 78352097. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 3, 2017. This trademark is owned by Amylin Pharmaceuticals, Inc.. The SYMLIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders
symlin

General Information

Serial Number78352097
Word MarkSYMLIN
Filing DateWednesday, January 14, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 3, 2017
Registration Number3121503
Registration DateTuesday, July 25, 2006
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 16, 2005

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of The word "Symlin" in a stylized font with an elliptical design above the letter "i".
Goods and ServicesPharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders
Lining/Stippling StatementThe stippling is for shading purposes only.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 3, 2017
Primary Code005
First Use Anywhere DateWednesday, April 27, 2005
First Use In Commerce DateWednesday, April 27, 2005

Trademark Owner History

Party NameAMYLIN PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSAN DIEGO, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, March 3, 2017CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, July 25, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, March 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 31, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, October 21, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, October 21, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, October 20, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 29, 2011TEAS SECTION 8 & 15 RECEIVED
Thursday, February 26, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 26, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 13, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 13, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 25, 2006REGISTERED-PRINCIPAL REGISTER
Monday, June 12, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, June 2, 2006ASSIGNED TO LIE
Saturday, May 27, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 4, 2006STATEMENT OF USE PROCESSING COMPLETE
Monday, April 24, 2006USE AMENDMENT FILED
Thursday, May 4, 2006EXTENSION 1 GRANTED
Monday, April 24, 2006EXTENSION 1 FILED
Monday, April 24, 2006TEAS EXTENSION RECEIVED
Monday, April 24, 2006TEAS STATEMENT OF USE RECEIVED
Tuesday, November 8, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 16, 2005PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2005NOTICE OF PUBLICATION
Monday, April 18, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 15, 2005ASSIGNED TO LIE
Tuesday, April 12, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 5, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 28, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 28, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 20, 2004FINAL REFUSAL E-MAILED
Wednesday, October 20, 2004FINAL REFUSAL WRITTEN
Tuesday, October 5, 2004ASSIGNED TO EXAMINER
Thursday, September 23, 2004TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 27, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 27, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 27, 2004NON-FINAL ACTION E-MAILED
Friday, February 27, 2004ASSIGNED TO EXAMINER
Wednesday, January 21, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

symlin disorders pharmaceutical preparations diabetic complications diseases hormonal diabetes endocrine namely